VideoNew Insights on Treatment of Veterans With CLL From ASH 2025Author:Nicholas R. Burwick, MDPublish date: January 26, 2026AVAHO President Nicholas Burwick discusses how insights from impactful phase 3 studies presented at ASH 2025 could expand treatment options for vet...Read More
VideoDiffuse Large B-Cell Lymphoma Highlights From ASH 2023Author:Nicholas R. Burwick, MDPublish date: January 3, 2024DLBCL highlights from ASH 2023 include chemotherapy-free regimens in frontline and recurrent settings as well as data on racial disparities in DLBC...Read More
ArticleChronic Lymphocytic Leukemia Highlights From ASH 2022 Author:Nicholas R. Burwick, MDPublish date: January 11, 2023CLL treatments from ASH 2022 include pirtobrutinib in pretreated patients, zanubrutinib in relapsed/refractory disease, and frontline ibrutinib + v...Read More
